| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | 4.03% | Jefferies | $6 → $8 | Maintains | Hold |
| 05/05/2023 | -8.97% | Goldman Sachs | $7.9 → $7 | Maintains | Neutral |
| 02/08/2023 | 2.73% | Goldman Sachs | $9.1 → $7.9 | Maintains | Neutral |
| 01/10/2023 | 18.34% | Goldman Sachs | $10.5 → $9.1 | Maintains | Neutral |
| 01/10/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 12/21/2021 | 95.06% | Goldman Sachs | $18 → $15 | Maintains | Neutral |
| 12/20/2021 | 95.06% | Goldman Sachs | $18 → $15 | Downgrades | Buy → Neutral |
| 04/15/2021 | 147.07% | Baird | $16 → $19 | Downgrades | Outperform → Neutral |
| 04/24/2020 | 82.05% | Baird | $19 → $14 | Maintains | Outperform |
| 04/08/2020 | 121.07% | RBC Capital | $20 → $17 | Maintains | Outperform |
| 11/27/2019 | 121.07% | Stifel | $19 → $17 | Downgrades | Buy → Hold |
| 11/25/2019 | 160.08% | RBC Capital | $21 → $20 | Maintains | Outperform |
| 07/18/2019 | 134.07% | JP Morgan | → $18 | Downgrades | Overweight → Neutral |
| 05/03/2019 | — | Credit Suisse | Assumes | → Neutral | |
| 02/13/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
| 02/12/2019 | 186.09% | Nomura | $25 → $22 | Maintains | Buy |
| 10/15/2018 | 134.07% | Baird | $22 → $18 | Maintains | Outperform |
| 08/10/2018 | 186.09% | Credit Suisse | $24 → $22 | Maintains | Neutral |
| 08/10/2018 | 251.11% | JP Morgan | $28 → $27 | Maintains | Overweight |
| 07/23/2018 | 225.1% | Jefferies | → $25 | Initiates Coverage On | → Buy |
| 07/23/2018 | 212.09% | Credit Suisse | → $24 | Initiates Coverage On | → Neutral |
| 07/23/2018 | 251.11% | Nomura | → $27 | Initiates Coverage On | → Buy |
| 07/23/2018 | 225.1% | Stifel | → $25 | Initiates Coverage On | → Buy |
| 07/23/2018 | 264.11% | JP Morgan | → $28 | Initiates Coverage On | → Overweight |
| 07/23/2018 | 238.1% | RBC Capital | → $26 | Initiates Coverage On | → Outperform |
| 07/23/2018 | 238.1% | Baird | → $26 | Initiates Coverage On | → Outperform |
| 07/23/2018 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/23/2018 | 238.1% | Goldman Sachs | → $26 | Initiates Coverage On | → Buy |
What is the target price for BrightView Hldgs (BV)?
The latest price target for BrightView Hldgs (NYSE: BV) was reported by Jefferies on July 13, 2023. The analyst firm set a price target for $8.00 expecting BV to rise to within 12 months (a possible 4.03% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BrightView Hldgs (BV)?
The latest analyst rating for BrightView Hldgs (NYSE: BV) was provided by Jefferies, and BrightView Hldgs maintained their hold rating.
When is the next analyst rating going to be posted or updated for BrightView Hldgs (BV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightView Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightView Hldgs was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
Is the Analyst Rating BrightView Hldgs (BV) correct?
While ratings are subjective and will change, the latest BrightView Hldgs (BV) rating was a maintained with a price target of $6.00 to $8.00. The current price BrightView Hldgs (BV) is trading at is $7.69, which is within the analyst's predicted range.